Address
Email address
Phone number
Website
https://www.terviseuuringud.eeTerviseuuringud - arsti vastuvõtt, vereanalüüsid, EKG koormustestOluline on läbida terviseuuring, et ennetada ja maandada tervisega seotud riske. Terviseuuring sisaldab: arsti vastuvõtt, vereanalüüsid, koormustest
Name
Health Tests OÜ
Registry code
12702440
VAT number
EE101743473
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
11.08.2014 (10)
Financial year
01.01-31.12
Capital
2 500.00 €
Activity
86221 - Provision of specialised medical treatment
205 232 €
335 €
0%
1 323 €
(estimate is approximate)
15 078 €
4
Submitted
No tax arrears
2%
1%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Silver Uustalu 28.12.1984 (39) | 100% - 2 500.00 EUR | Board member | Direct ownership | Founder |
| Artjom Timtšuk 26.02.1990 (34) | - | Board member | - | |
| Sirje Uustalu 10.10.1951 (72) | - | - | - | Founder |
| 2019 20.06.2020 | 2020 30.06.2021 | 2021 10.06.2022 | 2022 30.06.2023 | 2023 28.06.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 120 615 € | 112 998 € | 114 646 € | 186 879 € | 205 232 € |
| Net profit (loss) for the period | 18 339 € | -6 867 € | 4 913 € | 844 € | 335 € |
| Profit Margin | 15% | -6% | 4% | 0% | 0% |
| Current Assets | 20 602 € | 13 069 € | 26 749 € | 18 057 € | 11 454 € |
| Fixed Assets | 16 048 € | 9 544 € | 3 699 € | 26 824 € | 22 141 € |
| Total Assets | 36 650 € | 22 613 € | 30 448 € | 44 881 € | 33 595 € |
| Current Liabilities | 13 595 € | 11 507 € | 14 430 € | 22 961 € | 18 517 € |
| Non Current Liabilities | 0 € | - | - | 5 058 € | 0 € |
| Total Liabilities | - | - | - | 28 019 € | - |
| Share Capital | - | - | - | - | - |
| Equity | 23 055 € | 11 106 € | 16 018 € | 16 862 € | 15 078 € |
| Employees | 2 | 2 | 4 | 4 | 4 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 3 048.31 € | 8 783.72 € | 8 644.8 € | 14 |
| 2023 Q4 | 16 368.46 € | 9 918.31 € | 7 055.31 € | 14 |
| 2023 Q3 | 18 318.61 € | 11 098.14 € | 8 262.19 € | 6 |
| 2023 Q2 | 3 226.62 € | 9 814.88 € | 10 204.09 € | 8 |
| 2023 Q1 | 7 847.45 € | 9 235.84 € | 9 281.71 € | 12 |
| 2022 Q4 | 20 968.98 € | 9 956.34 € | 6 424.17 € | 12 |
| 2022 Q3 | 18 691.2 € | 7 953.66 € | 4 767.69 € | 11 |
| 2022 Q2 | 3 502.13 € | 11 436.24 € | 11 693.56 € | 10 |
| 2022 Q1 | 6 745.39 € | 6 146.73 € | 5 444.52 € | 10 |
| 2021 Q4 | 7 518.47 € | 5 806.65 € | 4 722.56 € | 7 |
| 2021 Q3 | 2 500 € | 5 417.95 € | 5 326.16 € | 6 |
| 2021 Q2 | 2 743.65 € | 3 871.47 € | 3 636.49 € | 6 |
| 2021 Q1 | 2 187.07 € | 5 419.52 € | 5 137.51 € | 5 |
| 2020 Q4 | 2 972.07 € | 6 661.87 € | 6 258.68 € | 6 |
| 2020 Q3 | 3 214.22 € | 8 119.16 € | 7 360.86 € | 6 |
| 2020 Q2 | 2 615.83 € | 847.5 € | 648.96 € | 5 |
| 2020 Q1 | 8 236.18 € | 5 375.98 € | 4 070.06 € | 5 |
